- Maze treatments (Nasdak:mazeThe stocks rose 45 % Premarket on Thursday after the biomedical pharmaceutical company announced a special stock to raise total revenues of about 150.0 million dollars.
- The offer includes 4,000,002 shares at $ 16.25 each, which is in addition to
https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png
2025-09-11 11:45:00
